Meiwu Technology Company Ltd Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $7.1M+4,368.0% YoYTTM through 31 Dec 2025
Net Income -$18.6M-463.5% YoYTTM through 31 Dec 2025
Free Cash Flow $9MTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| Gross Margin | 10.1% |
| EBITDA Margin | -83.3% |
| Operating Margin | -124.3% |
| Net Margin | -262.5% |
Returns
-36.8%ROE
-35.9%ROA
Balance Sheet Health
Debt / Equity0.00x
Current Ratio15.81x
Net Debt-$17.9Mnet cash position
Cash & Equivalents$17.9M
Quality Metrics
Altman Z-Score26.47
Piotroski F-Score3 / 9
FCF Margin127.1%
Multi-Year Trend
RevenueFY2025: $7.1M
Diluted EPS-$0.82TTMFY2025: $-0.84
Dividend
No dividend
Capital Allocation
R&D Spend$2.7M
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Skincare Products & Service | $7.1M | View detailsThe company is shifting its focus entirely toward the functional skincare market, utilizing AI and data-analysis technologies to build a skincare management platform. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.